This week, five health care provider stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Cross Country Healthcare, Inc. (CCRN) ups its rating to a B (“buy”) this week after earning a C (“hold”) in the week before. Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. Shares of the stock have been changing hands at an unusually rapid pace, twice the rate of the week prior. For more information, get Portfolio Grader’s complete analysis of CCRN stock.
Triple-S Management Corporation Class B’s (GTS) ratings are looking better this week, moving up to a C from last week’s A. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.
Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS) is seeing ratings go up from a C last week to a B this week. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. For more information, get Portfolio Grader’s complete analysis of FMS stock.
Bio-Reference Laboratories, Inc. (BRLI) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.
DaVita HealthCare Partners Inc. (DVA) improves from a C to a B rating this week. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.